Highlights of US CDER drug safety activity in 2003

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2004年 / 1005卷 / 1期

关键词：

Public Health; Medication Error; Product Testing; Drug Evaluation; Prescription Medicine;

D O I：

10.2165/00128415-200410050-00005

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[31] An overview of the CDER drug recall root cause research project
Torbeck, Lynn
Friedman, Richard
Smedley, Michael
Pharmaceutical Technology, 2009, 33 (08): : 42 - 45
[32] Patterns of Insufficient Physical Activity in US Adults, 2003
Ham, Sandra A.
Yore, Michelle M.
Kruger, Judy
Kohl, Bill
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2005, 37 : S328 - S329
[33] Icos reports 2003 highlights
不详
DRUG NEWS & PERSPECTIVES, 2004, 17 (02) : 99 - 148
[34] 2002 highlights and 2003 predictions
Christie, K
PHI DELTA KAPPAN, 2002, 84 (04) : 261 - 263
[35] Highlights and implications of the 2019 proposed rule on sunscreens by the US Food and Drug Administration
Wang, Steven Q.
Lim, Henry W.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (02) : 650 - 651
[36] Evidence Supporting US Food and Drug Administration Drug Safety Communications
Ross, Joseph S.
JAMA INTERNAL MEDICINE, 2019, 179 (11) : 1592 - 1592
[37] Canadian and US drug approval times and safety considerations
Rawson, NSB
Kaitin, KI
ANNALS OF PHARMACOTHERAPY, 2003, 37 (10) : 1403 - 1408
[38] The precautionary principle and the regulation of US food and drug safety
Soule, E
JOURNAL OF MEDICINE AND PHILOSOPHY, 2004, 29 (03): : 333 - 350
[39] Report from the World Drug Safety Congress US
不详
PHARMACEUTICAL MEDICINE, 2018, 32 (04) : 313 - 314
[40] The US FDA requires a “new vision of drug safety”
Reactions Weekly, 2006, 1126 (1) : 3 - 3

← 1 2 3 4 5 →